This is the authors' abstract. We don't add key points for this paper.
Presentation of CaseA 47-year-old man with relapsed acute myelogenous leukemia was admitted to the hospital for an allogeneic bone marrow transplantation.The patient had been well until 13 months earlier, when lymphadenopathy developed abruptly and he received a diagnosis of acute myelogenous leukemia, subtype M2 according to the French-American-British classification. He underwent induction chemotherapy with idarubicin and cytarabine. Because of persistent evidence of leukemia in a bone marrow specimen obtained on day 14 he received a second course of the same agents. Complications of chemotherapy included a dental abscess, streptococcal bacteremia, an intestinal helminthic infestation, and oral mucositis due . . .
No takes yet. Share an insight, caveat, or question.
Cabot et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: